1. Home
  2. HROW vs AFYA Comparison

HROW vs AFYA Comparison

Compare HROW & AFYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HROW
  • AFYA
  • Stock Information
  • Founded
  • HROW 1998
  • AFYA 1999
  • Country
  • HROW United States
  • AFYA Brazil
  • Employees
  • HROW N/A
  • AFYA N/A
  • Industry
  • HROW Biotechnology: Pharmaceutical Preparations
  • AFYA Other Consumer Services
  • Sector
  • HROW Health Care
  • AFYA Real Estate
  • Exchange
  • HROW Nasdaq
  • AFYA Nasdaq
  • Market Cap
  • HROW 1.4B
  • AFYA 1.4B
  • IPO Year
  • HROW N/A
  • AFYA 2019
  • Fundamental
  • Price
  • HROW $39.74
  • AFYA $14.96
  • Analyst Decision
  • HROW Strong Buy
  • AFYA Hold
  • Analyst Count
  • HROW 7
  • AFYA 5
  • Target Price
  • HROW $68.50
  • AFYA $18.10
  • AVG Volume (30 Days)
  • HROW 889.7K
  • AFYA 105.2K
  • Earning Date
  • HROW 11-12-2025
  • AFYA 11-12-2025
  • Dividend Yield
  • HROW N/A
  • AFYA 1.54%
  • EPS Growth
  • HROW N/A
  • AFYA 20.40
  • EPS
  • HROW N/A
  • AFYA 1.36
  • Revenue
  • HROW $227,661,000.00
  • AFYA $650,778,153.00
  • Revenue This Year
  • HROW $43.92
  • AFYA $14.67
  • Revenue Next Year
  • HROW $41.32
  • AFYA $8.42
  • P/E Ratio
  • HROW N/A
  • AFYA $11.11
  • Revenue Growth
  • HROW 47.69
  • AFYA 15.60
  • 52 Week Low
  • HROW $20.85
  • AFYA $13.47
  • 52 Week High
  • HROW $59.23
  • AFYA $19.90
  • Technical
  • Relative Strength Index (RSI)
  • HROW 45.21
  • AFYA 44.30
  • Support Level
  • HROW $40.79
  • AFYA $14.80
  • Resistance Level
  • HROW $48.79
  • AFYA $15.55
  • Average True Range (ATR)
  • HROW 2.41
  • AFYA 0.41
  • MACD
  • HROW -0.87
  • AFYA -0.09
  • Stochastic Oscillator
  • HROW 11.18
  • AFYA 26.65

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.

About AFYA Afya Limited

Afya Ltd is a medical education group based in Brazil. Its education portfolio has several courses in addition to Medicine, such as Management, Dentistry, Law, Engineering, Nursing, Psychology, and Accounting Sciences, among others. It has three segments; Undergrad provides educational services through undergraduate courses related to medical school, undergraduate health science and other ex-health undergraduate programs, Continuing Education provides medical education, specialization and graduate courses in medicine, delivered through digital and in-person content; and Medical practice solution provides clinical decision, clinical management and doctor-patient relationships for physicians and provide access, demand and efficiency for the healthcare players.

Share on Social Networks: